High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
J Clin Oncol Kyriakou et al 26:10.1200/JCO.2008.12.6219
Publisher’s Note
The January 10, 2008, article by Kyriakou et al, entitled, “High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation” (J Clin Oncol 26:218-224, 2008) was published online December 10, 2007 with an error.
The DOI no. was originally given as 10.1200/JCO.2007.12.6219, and should have been 10.1200/JCO.2008.12.6219.
This has been corrected as of April 1, 2009.
|
